AngioDynamics Announces Appointment of Former Johnson & Johnson Executive Karen Licitra to its Board of Directors
LATHAM, N.Y.–(BUSINESS WIRE)–Jul. 31, 2019– AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the appointment of Karen Licitra to its board of directors as a Class III director, effective July 17, 2019.
“We are eager to work with Ms. Licitra and believe that her extensive medical device, policy, and leadership experience will be invaluable to us as we execute our strategy and become a leaner, more innovation-focused company,” said Jim Clemmer, President and Chief Executive Officer of AngioDynamics, Inc. “Attracting top talent is a key component of our growth strategy, and we look forward to Ms. Licitra’s contributions as an outstanding addition to our board.”
“I’m honored to join the board and share my experience with the dynamic team Jim has built. I look forward to supporting AngioDynamics’ continued growth and its focus on improving patient care,” commented Ms. Licitra.
Ms. Licitra served as Corporate Vice President for Worldwide Government Affairs & Policy at Johnson & Johnson, a medical device, pharmaceutical, and consumer packaged goods manufacturer from January 2014 through August 2015. From December 2011 to December 2013, Ms. Licitra served as the Worldwide Chairman, Global Medical Solutions at Johnson & Johnson. From July 2002 to November 2011, she served as the Company Group Chairman and Worldwide Franchise Chairman at Ethicon Endo-Surgery, Inc., a Johnson & Johnson medical device company. From January 2001 to June 2002, she served as the President of Ethicon Endo-Surgery. Ms. Licitra has been a member of the board of directors of Si-Bone, Inc. (Nasdaq: SIBN) since August 2015. Ms. Licitra earned a Bachelor of Science degree in Commerce from Rider College.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190731005955/en/
Source: AngioDynamics, Inc.
Investor Relations:
AngioDynamics, Inc.
Michael Greiner
518-795-1821
mgreiner@angiodynamics.com
Media:
AngioDynamics, Inc.
Saleem Cheeks
518-795-1174
scheeks@angiodynamics.com